Evogene Ltd (NASDAQ:EVGN)

3.03
Delayed Data
As of Jun 18
 -0.07 / -2.26%
Today’s Change
2.66
Today|||52-Week Range
5.75
-1.30%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close3.10
Today’s open3.04
Day’s range2.90 - 3.12
Volume18,037
Average volume (3 months)10,886
Market cap$74.7M
Data as of 4:00pm ET, 06/18/2018

Growth & Valuation

Earnings growth (last year)-5.19%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-48.30%
P/E ratioNM
Price/Sales25.33
Price/Book1.08

Competitors

 Today’s
change
Today’s
% change
ADVMAdverum Biotechnolog...0.000.00%
AXSMAxsome Therapeutics ...+0.02+0.78%
--Wang On Group Ltd-0.00-20.00%
PSTIPluristem Therapeuti...-0.02-1.57%
Data as of 4:00pm ET, 06/18/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$3.4M
Annual profit (last year)-$20.8M
Net profit margin-616.33%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Operating Officer
Yuval Ben-Galim
Corporate headquarters
Rehovot, Hamerkaz

Forecasts